Achievement

Lucidum Achieves SOC 2 Type 1 Completion

Retrieved on: 
Wednesday, August 31, 2022

Lucidum, Inc. , the leading attack surface management platform, today announced that it has achieved SOC 2 Type 1 compliance in accordance with American Institute of Certified Public Accountants (AICPA) standards for Systems and Organization Controls (SOC).

Key Points: 
  • Lucidum, Inc. , the leading attack surface management platform, today announced that it has achieved SOC 2 Type 1 compliance in accordance with American Institute of Certified Public Accountants (AICPA) standards for Systems and Organization Controls (SOC).
  • SOC 2 Type 1 examinations assess organizations credibility for handling and protecting customers sensitive financial data.
  • We all know data is powerful but with this information comes an abundance of responsibility, said Charles Feng, co-founder and CTO, Lucidum.
  • We trust Lucidums commitment to security assurance and are proud to see it achieve SOC 2 Type 1 compliance.

Educational Support for Students Reaches New Levels with Paper's™ 2022-2023 Platform Upgrades

Retrieved on: 
Wednesday, August 31, 2022

The new features will be available to all 2.5 million students on the Paper platform just in time for the 2022-2023 school year.

Key Points: 
  • The new features will be available to all 2.5 million students on the Paper platform just in time for the 2022-2023 school year.
  • Included in the Paper ESS at no additional cost, Paper Math helps improve math comprehension and confidence for students of all grades.
  • Free to all Paper students, these walk-in-friendly classes will make students of any age love learning.
  • This certification is a significant step toward verifying the effectiveness of the educational support Paper's platform provides to students.

Kubient Receives Notice of Allowance for Patent-Pending Solution KAI

Retrieved on: 
Wednesday, August 31, 2022

A notice of allowance is issued by the USPTO to indicate that the application has passed examination.

Key Points: 
  • A notice of allowance is issued by the USPTO to indicate that the application has passed examination.
  • Receiving the Notice of Allowance for our patent-pending solution is a major milestone for Kubient, and we believe that is also a rather rare achievement within the AdTech industry, said Paul Roberts, Founder and CEO of Kubient.
  • This notice validates our approach to fraud prevention and brings Kubient one more step closer to more seamlessly scaling and widely commercializing our solution.
  • Kubient is continuing to invest in KAI's fraud AI/machine learning models and developing KAI to be the optimal intelligence layer between buyers and sellers.

qBotica Makes its Debut on the Acclaimed Inc. 5000 List of Fastest-Growing Private Companies

Retrieved on: 
Wednesday, August 31, 2022

The Inc. 5000 distinction recognizes certain private companies using a complicated set of quantitative metrics.

Key Points: 
  • The Inc. 5000 distinction recognizes certain private companies using a complicated set of quantitative metrics.
  • qBotica has proudly made its debut on the distinguished list.
  • Founded in 2017, qBotica is an innovative Intelligent 'Automation as a Service' provider, building highly adaptable automation ecosystems for our customers.
  • The company has transformed the automation journeys of companies in the financial services, manufacturing, transportation, healthcare, telecommunications, and high-tech industries.

Velontra Contracts with Venus Aerospace to Deliver a Propulsion System Enabling Airflights Around the Globe in One Hour

Retrieved on: 
Wednesday, August 31, 2022

CINCINNATI, Aug. 31, 2022 /PRNewswire/ -- Cincinnati/Dayton-based Velontra has partnered with Venus Aerospace in Houston, Texas, to develop a revolutionary propulsion system.

Key Points: 
  • CINCINNATI, Aug. 31, 2022 /PRNewswire/ -- Cincinnati/Dayton-based Velontra has partnered with Venus Aerospace in Houston, Texas, to develop a revolutionary propulsion system.
  • Keane also says that this contract with Venus Aerospace is a validation of the market need for the Velontra propulsion system that can carry passengers quickly and efficiently around the globe.
  • Velontra is a prime example of this," says Dr. Andrew Duggleby, chief technology officer and co-founder of Venus Aerospace.
  • "This investment achievement and our cutting-edge work with Venus Aerospace has created a path to groundbreaking success."

Quris Earns Frost & Sullivan 2022 Europe Technology Innovation Leadership Award for AI-Powered Drug Safety Prediction

Retrieved on: 
Wednesday, August 31, 2022

SAN ANTONIO, Aug. 31, 2022 /PRNewswire/ -- Frost & Sullivan recently researched the artificial intelligence (AI)-enabled drug safety prediction technology industry and, based on its findings, recognizes Quris with the 2022 Europe Technology Innovation Leadership Award. The innovative Quris Bio-AI Clinical Prediction Platform is the first AI breakthrough to close the clinical prediction gap by effectively predicting which drug candidates will work safely in humans.

Key Points: 
  • Analysts found that the Quris Bio-AI Clinical Prediction Platform enhances drug development process agility, shortens discovery timelines, increases drug safety, and improves drug pipeline diversification opportunities
    SAN ANTONIO, Aug. 31, 2022 /PRNewswire/ -- Frost & Sullivan recently researched the artificial intelligence (AI)-enabled drug safety prediction technology industry and, based on its findings, recognizes Quris with the 2022 Europe Technology Innovation Leadership Award.
  • The innovative Quris Bio-AI Clinical Prediction Platform is the first AI breakthrough to close the clinical prediction gap by effectively predicting which drug candidates will work safely in humans.
  • "Quris AI Chip-on-Chip platform, unlike other AI-pharma solutions focusing on drug discovery, better indicates which drug candidates will safely work in humans.
  • In addition to its drug safety prediction pharma services, Quris also has a drug pipeline and provides personalized medicine services.

National Report Reveals Need for Data-Driven Instructional Coaching Programs to Support Teachers and Improve Student Outcomes

Retrieved on: 
Wednesday, August 31, 2022

NEW YORK, Aug. 31, 2022 /PRNewswire/ -- As we begin the fourth straight school year impacted by COVID pandemic learning disruptions, the challenge of retaining high quality teachers is a critical issue in U.S. public schools. Implementing strategies and refocusing resources on areas such as instructional coaching is more important than ever as school leaders look to create more collaborative and supportive environments for their teachers.

Key Points: 
  • The report titled, " Coaching Impact Report: Practices, tools, and trends affecting instructional coaching programs ," surveyed nearly 100 district leaders and coaches around the country about practices, tools, and trends driving instructional coaching programs.
  • The report highlights both bright spots and growth areas and provides valuable insight for district and instructional leaders who are working to build successful, sustainable coaching programs.
  • Through the use of data, schools can ensure teachers are receiving the support needed and students are receiving high quality instruction.
  • Key findings of the report include:
    Educators surveyed shared that most districts (75%) see the connection between coaching, teacher growth, and student achievement.

Quris Earns Frost & Sullivan 2022 Europe Technology Innovation Leadership Award for AI-Powered Drug Safety Prediction

Retrieved on: 
Wednesday, August 31, 2022

SAN ANTONIO, Aug. 31, 2022 /PRNewswire/ -- Frost & Sullivan recently researched the artificial intelligence (AI)-enabled drug safety prediction technology industry and, based on its findings, recognizes Quris with the 2022 Europe Technology Innovation Leadership Award. The innovative Quris Bio-AI Clinical Prediction Platform is the first AI breakthrough to close the clinical prediction gap by effectively predicting which drug candidates will work safely in humans.

Key Points: 
  • Analysts found that the Quris Bio-AI Clinical Prediction Platform enhances drug development process agility, shortens discovery timelines, increases drug safety, and improves drug pipeline diversification opportunities
    SAN ANTONIO, Aug. 31, 2022 /PRNewswire/ -- Frost & Sullivan recently researched the artificial intelligence (AI)-enabled drug safety prediction technology industry and, based on its findings, recognizes Quris with the 2022 Europe Technology Innovation Leadership Award.
  • The innovative Quris Bio-AI Clinical Prediction Platform is the first AI breakthrough to close the clinical prediction gap by effectively predicting which drug candidates will work safely in humans.
  • "Quris AI Chip-on-Chip platform, unlike other AI-pharma solutions focusing on drug discovery, better indicates which drug candidates will safely work in humans.
  • In addition to its drug safety prediction pharma services, Quris also has a drug pipeline and provides personalized medicine services.

Barnes & Noble Education and University of Connecticut to Launch Husky Book Bundle, a BNC First Day® Complete Program to Enhance Student Outcomes

Retrieved on: 
Wednesday, August 31, 2022

Barnes & Noble Education, Inc. (NYSE: BNED) , a leading solutions provider for the education industry, today announced the upcoming launch of First Day Complete at the University of Connecticut (UConn).

Key Points: 
  • Barnes & Noble Education, Inc. (NYSE: BNED) , a leading solutions provider for the education industry, today announced the upcoming launch of First Day Complete at the University of Connecticut (UConn).
  • First Day Complete is available to all undergraduates attending UConns five campuses, including the main campus in Storrs and regional campuses in Avery Point, Hartford, Stamford, and Waterbury.
  • We are excited about our partnership with UConn as we implement First Day Complete to enhance student outcomes, said Jonathan Shar, President, Barnes & Noble College.
  • Barnes & Noble College, a Barnes & Noble Education company, currently operates more than 770 campus stores nationwide.

Semarchy CEO TH Herbert Accepted into Forbes Business Council

Retrieved on: 
Wednesday, August 31, 2022

PHOENIX,  Aug. 31, 2022 /PRNewswire-PRWeb/ -- TH Herbert, CEO of Semarchy, a software leader that enables organizations to leverage their data to create business value, has been accepted into the Forbes Business Council, the foremost growth and networking organization for successful business owners and leaders worldwide.

Key Points: 
  • PHOENIX, Aug. 31, 2022 /PRNewswire-PRWeb/ -- TH Herbert, CEO of Semarchy , a software leader that enables organizations to leverage their data to create business value, has been accepted into the Forbes Business Council, the foremost growth and networking organization for successful business owners and leaders worldwide.
  • "We are pleased to welcome TH Herbert into the community," said Scott Gerber, founder of Forbes Councils, the collective that includes Forbes Business Council.
  • "I am honored and excited by this opportunity to join the Forbes Business Council," said Herbert.
  • Prior to taking on the role of CEO at Semarchy, Herbert was the chief operations officer and sales leader for Semarchy.